MarketScreener Strategies Protagonist Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2025-12-05 EST			5-day change	1st Jan Change
89.65 ^USD	+2.66%		-0.39%	+132.25%

11-06	Protagonist Therapeutics Q3 net loss widens to $39.3 mln	RE
11-06	Earnings Flash (PTGX) Protagonist Therapeutics, Inc. Reports Q3 Revenue $4.7M, vs. FactSet Est of $3.8M	MT

No results for this search